Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of dtat-ha2 in China, also supports custom service. Welcome to wholesale bulk high quality dtat-ha2 from our factory. Contact us for more details.
| Description | dTAT-HA2 is a chimeric fusion peptide composed entirely of D-amino acids, fusing the cell-penetrating domain of HIV-1 TAT protein with the membrane fusion peptide sequence from the influenza virus hemagglutinin HA2 subunit. The TAT portion confers efficient cell-penetrating ability, enabling cellular entry through binding to heparan sulfate proteoglycans on the cell membrane and the macropinocytosis pathway; the HA2 portion is a pH-sensitive lipid membrane destabilizing sequence that undergoes a conformational change in the acidic endosomal environment (protonation of glutamic and aspartic acids triggers a helical transition), thereby disrupting the endosomal membrane and achieving endosomal escape to release cargo into the cytoplasm. The all-D-amino acid configuration gives this peptide excellent resistance to proteolytic degradation, showing higher stability in both in vivo and in vitro experiments. dTAT-HA2 is widely used in intracellular delivery research for siRNA, proteins, peptide drugs, and nanoparticles, especially in delivery systems requiring efficient endosomal escape. |
| Molecular formula | C₁₃₇H₂₁₉N₄₅O₃₇S |
| Molecular weight (Da) | ~3120.6 |
| Structure type | Linear fusion peptide (all D-amino acids, TAT-HA2 chimera) |
| Solubility | Freely soluble in water, PBS |
| Storage | Condition Powder at -20°C, dry and protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| dTAT-HA2 | Dimeric TAT-HA2 fusion peptide; endosome-escape CPP | Cell-penetrating peptide, endosomal escape, transfection enhancement, nucleic acid delivery | Fusion peptide composed of dimeric TAT CPP and influenza hemagglutinin HA2 endosomal escape domain; TAT mediates cell penetration, HA2 undergoes conformational change in acidic endosomes to disrupt endosomal membranes and promote cargo release, significantly improving transfection efficiency | C₁₄₅H₂₄₅N₅₅O₃₁S | 3341.87 | ~3344.1 | Acetate | 28 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-DTAT-HA | White powder | Store at -20°C, sealed, dry and protected from light. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. | Stable for 7 days at 4°C under neutral conditions. Soluble in dilute acetic acid and acidic buffers. Structurally stable at neutral pH; HA2 domain undergoes conformational change and exerts membrane fusion activity under acidic pH (endosomal environment). | Stable for 2 years at -20°C, dry and protected from light. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-DTAT-HA | dTAT-HA2 endosome-escape fusion peptide with dual penetration and release functions | dTAT-HA2 is a bifunctional endosome-escape cell-penetrating peptide, composed of a dimeric TAT domain fused to an influenza HA2 endosomal escape domain. Dimeric TAT enhances nucleic acid binding capacity and cell penetration efficiency. After cellular uptake, the HA2 domain undergoes conformational change in the acidic endosomal environment, disrupting endosomal membranes to release cargo into the cytosol. | Gene transfection & gene therapy, nucleic acid drug delivery, endosomal escape research, nanocarrier development, genetic engineering | Phospholipid bilayer; endosomal membrane; HA2 acid-activated conformational membrane fusion |
Hot Tags: dtat-ha2, China dtat-ha2 manufacturers, suppliers, factory, 203716-10-3, 651328-78-8, CAS 395069 92 8, CAS 651328 78 8, NGR peptide, Tetralysine
